Gw501516 Cardarine Endurobol Fat Loss Steroids Inhibitors for Bodybuilding 317318-70-0

본문 바로가기


Home > Product > Gw501516 Cardarine Endurobol Fat Loss Steroids Inhibitors for Bodybuilding 317318-70-0
Product
Gw501516 Cardarine Endurobol Fat Loss Steroids Inhibitors for Bodybuil...
Posting date : Nov 21, 2016
Membership
Free Member Scince Nov 21, 2016
FOB Price
1$
Min. Order Quantity
10g
Supply Abillity
1000kg per day
Port
Hong Kong
Payment Terms
Western union,Money Gram,Bank transfer and bitcoin
Package
Disguised
Keyword :
Category
Contact
Alex
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Jiaye
HS-CODE
-
Package & Delivery Lead Time
Package
Disguised
Delivery Lead Time
In 7 days
Detailed Description
GW-501516  Cardarine 
Gw501516 Cardarine Endurobol Fat Loss Steroids Inhibitors for Bodybuilding 317318-70-0
 
1.basic  info:
Color:Light Yellow Powder.      
Molecular Formula:C19H18F3N3O6
Molecular Weight: 453.5                      
Assay:99.9%CAS: 317318-70-0
Synonyms: 2-[2-Methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic Acid;Methyl-methyl-trifluoromethylphenyl -thiazolyl-methylsulfanyl-phenoxy-acetic Acid;2-(4-((2-(4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid;2-(2-methyl-4-((5-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-4-yl)methylthio)phenoxy)acetic acid;GW 1516;Cardarine;GSK-516
 
2.Product Description
GW501516 (also known as GW-501,516, GW1516, GSK-516) is a PPAR& receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.
 
3.GW501516 Usage:
GW501516 (also known as GW-501,516, GW1516, GSK-516 and Endurobol)is a PPAR receptor.It activates the same pathways activated through exercise, including PPAR and AMP-activated protein kinase. It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 has a synergistic effect when combined with AICAR: the combination has been shown to significantly increase exercise endurance in animal studies more than either compound .
An experimental drug meant to control lipids and increase the level of HDL, or good cholesterol, in the bloodstream. A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARδ agonist.Exhibits selectivity for PPARδ compared to PPARα and PPARγ. Does not exibit any activity against other nuclear or non-nuclear receptors. Reported to increase cholesterol efflux and ABAC1 expression in macrophages, fibroblasts, and intestinal cells. 
 
related products:
NAME          CAS
MK-2866       841205-47-8
GW-501516     317318-70-0   
Andarine S4   401900-40-1
LGD-4033      1165910-22-4
MK-677        159752-10-0 
RAD140        1182367-47-0
SR9009        1379686-30-2
YK11          431579-34-9
 

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top